Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities

Autor: Donatella Labella, Lucia Altucci, Anthony Tumber, Biagina Marrocco, Clarence Yapp, Giuseppe Ciossani, Dante Rotili, Oliver N. King, Marcello Tortorici, Sergio Valente, Richard J. Hopkinson, Stefano Tomassi, Mariarosaria Conte, Andrea Mattevi, Akane Kawamura, Ettore Novellino, Rosaria Benedetti, Antonello Mai, Christopher J. Schofield
Přispěvatelé: Rotili, D, Tomassi, S, Conte, M, Benedetti, R, Tortorici, M, Ciossani, G, Valente, S, Marrocco, B, Labella, D, Novellino, E, Mattevi, A, Altucci, Lucia, Tumber, A, Yapp, C, King, On, Hopkinson, Rj, Kawamura, A, Schofield, Cj, Mai, A., Dante, Rotili, Tomassi, Stefano, Mariarosaria, Conte, Rosaria, Benedetti, Marcello, Tortorici, Giuseppe, Ciossani, Sergio, Valente, Biagina, Marrocco, Donatella, Labella, Novellino, Ettore, Andrea, Mattevi, Lucia, Altucci, Anthony, Tumber, Clarence, Yapp, King, Oliver N. F., Hopkinson, Richard J., Akane, Kawamura, Schofield, Christopher J., Antonello, Mai
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Zdroj: Journal of Medicinal Chemistry; Vol 57
Journal of Medicinal Chemistry
Journal of medicinal chemistry 57 (2014): 42–55. doi:10.1021/jm4012802
info:cnr-pdr/source/autori:Rotili, Dante; Tomassi, Stefano; Conte, Mariarosaria; Benedetti, Rosaria; Tortorici, Marcello; Ciossani, Giuseppe; Valente, Sergio; Marrocco, Biagina; Labella, Donatella; Novellino, Ettore; Mattevi, Andrea; Altucci, Lucia; Tumber, Anthony; Yapp, Clarence; King, Oliver N. F.; Hopkinson, Richard J.; Kawamura, Akane; Schofield, Christopher J.; Mai, Antonello/titolo:Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities/doi:10.1021%2Fjm4012802/rivista:Journal of medicinal chemistry/anno:2014/pagina_da:42/pagina_a:55/intervallo_pagine:42–55/volume:57
DOI: 10.1021/jm4012802
Popis: In prostate cancer, two different types of histone lysine demethylases (KDM), LSD1/KDM1 and JMJD2/KDM4, are co-expressed and co-localize with the androgen receptor. We designed and synthesized hybrid LSD1/JmjC - "pan-KDM" - inhibitors 1-6, by coupling the skeleton of tranylcypromine 7, a known LSD1 inhibitor, with 4-carboxy-4'-carbomethoxy-2,2'-bipyridine 8 or 5-carboxy-8-hydroxyquinoline 9, two 2-oxoglutarate competitive templates developed for JmjC inhibition. Hybrid compounds 1-6 are able to simultaneously target both KDM families, and have been validated as potential antitumor agents in cells. Among them, compounds 2 and 3 increase H3K4 and H3K9 methylation levels in cells and cause growth arrest and substantial apoptosis in LNCaP prostate and HCT116 colon cancer cells. When tested in non-cancer mesenchymal progenitor (MePR) cells, 2 and 3 induced little and no apoptosis, respectively, thus showing a cancer-selective inhibiting action.
Databáze: OpenAIRE